These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8204678)

  • 21. An examination of the factor structure and convergent and discriminant validity of the SCL-90R in an outpatient clinic population.
    Brophy CJ; Norvell NK; Kiluk DJ
    J Pers Assess; 1988; 52(2):334-40. PubMed ID: 3404394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychiatric symptoms in mentally ill chemical abusers.
    Carey MP; Carey KB; Meisler AW
    J Nerv Ment Dis; 1991 Mar; 179(3):136-8. PubMed ID: 1997660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community residential program policies, services, and treatment orientations influence patients' participation in treatment.
    Moos RH; King MJ; Burnett EB; Andrassy JM
    J Subst Abuse; 1997; 9():171-87. PubMed ID: 9494948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A survey of mental health status in armored vehicle crew].
    Yang QL; Kao XB; Wu GB; Guo SW; Chai WL; Chen YN; Ji LJ; Wang YQ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2016 Jun; 34(6):429-32. PubMed ID: 27514551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse.
    Pagonis TA; Angelopoulos NV; Koukoulis GN; Hadjichristodoulou CS
    Eur Psychiatry; 2006 Dec; 21(8):551-62. PubMed ID: 16356691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A national survey of primary methamphetamine-related admissions to youth residential substance abuse treatment facilities in Canada, 2005 to 2006.
    Callaghan RC; Tavares J; Taylor L; Veldhuizen S
    Can J Psychiatry; 2007 Oct; 52(10):684-8. PubMed ID: 18020116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychopathology and personality characteristics in different forms of substance abuse.
    Campbell BK; Stark MJ
    Int J Addict; 1990 Dec; 25(12):1467-74. PubMed ID: 2094684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-Occurring Disorders: A Challenge for Mexican Community-Based Residential Care Facilities for Substance Use.
    Marín-Navarrete R; Medina-Mora ME; Horigian VE; Salloum IM; Villalobos-Gallegos L; Fernández-Mondragón J
    J Dual Diagn; 2016; 12(3-4):261-270. PubMed ID: 27494051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The functioning of individuals on a drug abuse treatment waiting list.
    Brown BS; Hickey JE; Chung AS; Craig RD; Jaffe JH
    Am J Drug Alcohol Abuse; 1989; 15(3):261-74. PubMed ID: 2763983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mental health symptoms and their relationship to cannabis use in adolescents attending residential treatment.
    Albertella L; Norberg MM
    J Psychoactive Drugs; 2012; 44(5):381-9. PubMed ID: 23457889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of psychiatric symptomatology on treatment outcome for adolescent male drug abusers.
    Friedman AS; Glickman NW
    J Nerv Ment Dis; 1987 Jul; 175(7):425-30. PubMed ID: 3598570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comorbidity structure of psychological disorders in the online e-PASS data as predictors of psychosocial adjustment measures: psychological distress, adequate social support, self-confidence, quality of life, and suicidal ideation.
    Al-Asadi AM; Klein B; Meyer D
    J Med Internet Res; 2014 Oct; 16(10):e248. PubMed ID: 25351885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug abuse day treatment: a randomized clinical trial comparing day and residential treatment programs.
    Guydish J; Werdegar D; Sorensen JL; Clark W; Acampora A
    J Consult Clin Psychol; 1998 Apr; 66(2):280-9. PubMed ID: 9583331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric dimensions in mothers of children with primary nocturnal enuresis: A controlled study.
    Durmaz O; Kemer S; Mutluer T; Bütün E
    J Pediatr Urol; 2017 Feb; 13(1):62.e1-62.e6. PubMed ID: 27665376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residential alternatives to hospitalization for patients with severe and persistent mental illness: should patients with comorbid substance abuse be excluded?
    Herrell JM; Fenton W; Mosher LR; Hedlund S; Lee B
    J Ment Health Adm; 1996; 23(3):348-55. PubMed ID: 10172714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes in community-based residential treatment and rehabilitation for individuals with psychiatric disabilities: a retrospective study.
    Vandevooren J; Miller L; O'Reilly R
    Psychiatr Rehabil J; 2007; 30(3):215-7. PubMed ID: 17269272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health care utilization and cost after discharge from a mental health hospital; an RCT comparing community residential aftercare and treatment as usual.
    Roos E; Bjerkeset O; Steinsbekk A
    BMC Psychiatry; 2018 Nov; 18(1):363. PubMed ID: 30419894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a new casino on problem gambling in treatment-seeking substance abusers.
    Toneatto T; Ferguson D; Brennan J
    Can J Psychiatry; 2003 Feb; 48(1):40-4. PubMed ID: 12635563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs.
    Broome KM; Flynn PM; Simpson DD
    Health Serv Res; 1999 Aug; 34(3):791-806. PubMed ID: 10445903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.